We would love to hear your thoughts about our site and services, please take our survey here.
there are much less sophisticated systems that solve issues nowhere near as big, that charge an arm and a leg and these companies have no problems paying for something that works. So I think the commercial model has been far too soft. fair enough to have free trials to get some names behind you, but have a review point early, show proof concept early and then charge and charge a lot more than what is being charged or we will need a fundraise, I don't see why it is anymore complicated than that
Roche has selected PathAI to collaborate with it on an artificial intelligence program that will be merged with its digital pathology work. From the webinar is concerning to me because we have Bryn Roberts as NED who is SVP & Global Head of Data Services at Roche! How the hell did they end up choosing the competition. Mark Warne out for me definitely!
I have been told I won;t get them until 4th March!
Could this be a bit of an overreaction? The company is on track, plenty of loss making revenue generating companies in their early days, the boost in revenue is the main thing here for the longer term prospects, think we have lost some short termers here that's all. the outlook still looks positive to me.
also, imagine if Elon turns up to this - https://www.livebitcoinnews.com/microstrategys-michael-saylor-to-host-btc-summit/
I think after an initial further shake, we will be seeing more inst buying
I have to disagree but as I said happy to wrong, the chartists seem to be saying this is a temporary pump but will hit resistance, and the gradual move down to 24k is definitely possible and in my opinion more likely, probs during the weekend early next week. Saying this all with the exception that BTC does not do a GME, WSB style, if it does a GME then happy days indeed!
Put this way companies of this size would pay multiple millions per year to companies such as Veeva and master control and medidata, who arguably are not doing anything as unique as dmtr ,
King homer so does that mean we think Merck would only be paying £150k per year? If so that's peanuts to them we could be charging way more. Or am I missing something ? Like how many units would they require potentially?
https://www.youtube.com/watch?v=ZCkN2MNGAew - Funky gives his view
https://uk.finance.yahoo.com/news/why-d-buy-argo-blockchain-123010932.html
https://www.theblockcrypto.com/linked/91094/institutions-doubled-down-on-their-bets